Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
c0U9jfDxeUBq423p
